“It was really fantastic journey while filing my case. I really impressed about the way of working by your team specially reviewer who reviewed each and every tiny things of the documents and also their suggestions were so meaningful.”

Case Summary:

When our client, an Indian assistant manager with a Master of Science and a Doctor of Philosophy in pharmacy, approached North America Immigration Law Group (NAILG) for assistance with EB-1A filing, we first evaluated his credentials. We were impressed with the 26 peer-reviewed scientific articles and two books he had published and the 293 citations that they had obtained. Moreover, the fact that he had conducted 39 peer reviews further showcased his respected standing in the field.

Based on our client’s aforementioned research achievements, we decided to represent his EB-1A case. After countersigning the legal agreement, we started assembling a well-structured petition that comprised of his scholarly contributions, recommendation letters, and other evidence of his extraordinary ability.

“There is a need for inexpensive and effective treatments to help the billions of people worldwide suffering from periodontal disease. As a member of the pharmaceutical sciences, [client] has developed a cost-effective antibiotic gel for the treatment of periodontal disease. The research of experts in the field of pharmaceutical sciences, like [client], is greatly needed to help combat common diseases for people who cannot afford the most expensive treatments.” This statement was taken from a recommendation letter in support of our client’s EB-1A (Alien of Extraordinary Ability) petition. Several other experts also contributed recommendation letters, all of which provided the USCIS with a clear picture of our client’s expertise in the field of pharmaceutical sciences.

We also demonstrated that our client’s research addresses some of the United States’ most pressing issues in understanding the best methods of developing more effective and less expensive pharmaceuticals. We persuaded the USCIS that his research directly aids the American medical and pharmaceutical industries and his achievements are of the utmost importance due to their contributions to human health and well-being.

In addition to carefully assembling the required documents to file the EB-1A petition on behalf of our client, our team has included a customized map for visualization to indicate that our client’s publications have been cited at a much higher rate than those of other researchers in the field, distinguishing him from his peers. The visual presentation of the data has indeed further demonstrated and supported the argument in the petition letter drafted by us.

We truly appreciate our client for trusting us with the preparation of his EB-1A case and for giving us an opportunity to be a part of his success story.